help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2007-0113
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
21/6/1312    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houten, S. M.
Right arrow Articles by Auwerx, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houten, S. M.
Right arrow Articles by Auwerx, J.
Molecular Endocrinology 21 (6): 1312-1323
Copyright © 2007 by The Endocrine Society

In Vivo Imaging of Farnesoid X Receptor Activity Reveals the Ileum as the Primary Bile Acid Signaling Tissue

Sander M. Houten1, David H. Volle1, Carolyn L. Cummins, David J. Mangelsdorf and Johan Auwerx

Institut de Génétique et Biologie Moléculaire et Cellulaire (S.M.H., D.H.V., J.A.), Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/Université Louis Pasteur, and Institut Clinique de la Souris (J.A.), 67404 Illkirch, France; Howard Hughes Medical Institute and Department of Pharmacology (C.L.C., D.J.M.), University of Texas Southwestern Medical Center, Dallas, Texas 75390; and Hôpitaux Universitaires de Strasbourg, Laboratoire de Biochimie Générale et Spécialisée (J.A.), 67000 Strasbourg, France

Address all correspondence and requests for reprints to: Johan Auwerx, Institut de Génétique et Biologie Moléculaire et Cellulaire, 1 Rue Laurent Fries, Parc d’Innovation, 67404 Illkirch, France. E-mail: auwerx{at}igbmc.u-strasbg.fr.

We generated and characterized a firefly luciferase reporter mouse for the nuclear receptor farnesoid X receptor (FXR). This FXR reporter mouse has basal luciferase expression in the terminal ileum, an organ with well-characterized FXR{alpha} signaling. In vivo luciferase activity reflected the diurnal activity pattern of the mouse, and is regulated by both natural (bile acids, chenodeoxycholic acid) and synthetic (GW4064) FXR{alpha} ligands. Moreover, in vivo and in vitro analysis showed luciferase activity after GW4064 administration in the liver, kidney, and adrenal gland, indicating that FXR{alpha} signaling is functional in these tissues. Hepatic luciferase activity was robustly induced in cholestatic mice, showing that FXR{alpha} signaling pathways are activated in this disease. In conclusion, we have developed an FXR reporter mouse that is useful to monitor FXR{alpha} signaling in vivo in health and disease. The use of this animal could facilitate the development of new therapeutic compounds that target FXR{alpha} in a tissue-specific manner.

NURSA Molecule Pages Link:

Nuclear Receptors:   FXRα
Ligands:   GW4064



This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
C. Mataki, B. C. Magnier, S. M. Houten, J.-S. Annicotte, C. Argmann, C. Thomas, H. Overmars, W. Kulik, D. Metzger, J. Auwerx, et al.
Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1
Mol. Cell. Biol., December 1, 2007; 27(23): 8330 - 8339.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society